Clinical Imaging
Volume 34, Issue 3 , Pages 196-202 , May 2010

Quantitative methodology using CT for predicting survival in patients with metastatic colorectal carcinoma: a pilot study

Received 5 November 2009 ,Revised 2 January 2010 ,Accepted 10 January 2010.

References 

  1. Clarke LP, Sriram RD, Schilling LB. Imaging as a biomarker: standards for change measurements in therapy workshop summary. Acad Radiol. 2008;15(4):501–530
  2. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol. 2003;21(7):1404–1411
  3. Curran SD, Mueliner AU, Schwartz LH. Imaging response assessment in oncology. Cancer Imaging. 2006;6:S126–S130
  4. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92(3):205–216
  5. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guidelines (version 1.1). Eur J Cancer. 2009;45(2):228–247
  6. Husband JE, Schwartz LH, Spencer J, et al. Evaluation of the response to treatment of solid tumours — a consensus statement of the international cancer imaging society. Br J Cancer. 2004;90(12):2256–2260
  7. Zhao B, Schwartz LH, Moskowitz CS, et al. Lung cancer: computerized quantification of tumor response — initial results. Radiology. 2006;241(3):892–898
  8. Schnall M, Rosen M. Primer on imaging technologies for cancer. J Clin Oncol. 2006;24(20):3225–3233
  9. Shankar LK, Sullivan DC. Functional imaging in lung cancer. J Clin Oncol. 2005;23(14):3203–3211
  10. Kelloff GJ, Hoffman JM, Johnson B, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res. 2005;11(8):2785–2808
  11. Smith JJ, Sorensen AG, Thrall JH. Biomarkers in imaging: realizing radiology's future. Radiology. 2003;227(3):633–638
  12. Tuma RS. Sometimes size doesn't matter: revaluating RECIST and tumor response rate end points. J Natl Cancer Inst. 2006;98(18):1272–1274
  13. Lesko LJ, Atkinson AJ. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41:347–366
  14. Pien HH, Fischman AJ, Thrall JH, et al. Using imaging biomarkers to accelerate drug development and clinical trials. Drug Discov Today. 2005;10(4):259–266
  15. D'Orsi CJ, Newell MS. BI-RADS decoded: detailed guidance on potentially confusing issues. Radiol Clin North Am. 2007;(5):751–763
  16. Lazarus E, Mainiero MB, Schepps B, et al. BI-RADS Lexicon for US and mammography: interobserver variability and positive predictive value. Radiology. 2006;239(2):385–391
  17. American College of Radiology . Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston, VA: American College of Radiology; 2003;
  18. Likert, R. (1932). A technique for the measurement of attitudes, archives of psychology, No.140.
  19. Rogers MP, Orav J, Black , et al. The use of a Simple Likert Scale to measure quality of life in brain tumor patients. J Neuro-Oncol. 2001;55:121–131
  20. Impellizzeri FM, Maffiuletti NA. Convergent evidence for construct validity of a 7-point Likert scale of lower limb muscle soreness. Clin J Sport Med. 2007;17(6):494–496
  21. Case LD, Kimmick G, Paskett ED, et al. Interpreting measures of treatment effect in cancer clinical trials. Oncologist. 2002;7(3):181–187
  22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174
  23. Langlotz CP. Automatic structuring of radiology reports: harbinger of a second information revolution in radiology. Radiology. 2002;222(1):5–7
  24. Alberts SR, Wagman LD. Chemotherapy for colorectal cancer liver metasteses. Oncologist. 2008;13(10):1063–1073Epub 2008 Oct 6
  25. Chhatwal J, Alagoz O, Lindstrom MJ, et al. A logistic regression model based on the national mammography database format to aid breast cancer diagnosis. AJR. 2009;192:1117–1127
  26. Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54:979–985
  27. Gareen IF, Gatsonis C. Primer on multiple regression models for diagnostic imaging research. Radiology. 2003;229:305–310
  28. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras Mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757–1765No.17
  29. Berg WA, D'Orsi CJ, Jackson VP, et al. Does training in the breast imaging reporting and data system (BI-RADS) improve biopsy recommendations or feature analysis agreement with experienced breast imagers at mammography?. Radiology. 2002;224(3):871–880

PII: S0899-7071(10)00008-2

doi: 10.1016/j.clinimag.2010.01.002

Clinical Imaging
Volume 34, Issue 3 , Pages 196-202 , May 2010

Article Tools

* Image Usage & Resolution